In the past few sessions, Intuitive Surgical, manufacturer of robotic surgical systems, have suffered from a sharp fall and is now placed near an attractive level of support.
In the recent months, the earnings estimates for the next year were regularly revised upward by analysts. With an EPS estimated at USD 14.87 for this year and USD 17.50 for the next year, Intuitive Surgical is rather expensive compared to competitors. The security is currently paid 33 times the results for 2012 against 22.5 times for the sector.
Technically, in daily data, even if moving averages are still in a downtrend, the recent positive reaction in the USD 472.50 area should limit this trend and allow a technical rebound towards USD 520.90. Moreover, technical indicators show a significant oversold condition which strengthens this bullish scenario.
Ideally, investors should wait for a drop close to the USD 472.50 threshold before taking a long position on Intuitive Surgical's security. Investors should not insist under USD 472.50 and are better to place a stop loss order under this area.
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows:
- sale of instruments and accessories (60%): primarily wrist cuffs;
- sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries;
- installation and training services (16.4%).
The United States accounts for 65.8% of net sales.
INTUITIVE SURGICAL, INC. 
